Search

Search Constraints

You searched for: Author/Creator Malis, Josef

Search Results

1. An unusual fusion gene EML4‐ALK in a patient with congenital mesoblastic nephroma. Issue 12 (22nd August 2021)

2. Busulfan and melphalan versus carboplatin, etoposide, and melphalan as high-dose chemotherapy for high-risk neuroblastoma (HR-NBL1/SIOPEN): an international, randomised, multi-arm, open-label, phase 3 trial. Issue 4 (April 2017)

3. Frequency and Prognostic Impact of ALK Amplifications and Mutations in the European Neuroblastoma Study Group (SIOPEN) High-Risk Neuroblastoma Trial (HR-NBL1). Issue 30 (20th October 2021)

5. Risk stratification of high‐risk metastatic neuroblastoma: A report from the HR‐NBL‐1/SIOPEN study. Issue 11 (17th July 2018)